All Episodes
Touching Base — 56 episodes
BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C.auris
Axiom’s Hong Kong Bet, Latigo’s Positive Phase II, and Base Editors for Huntington’s
Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics
Merck and Insilico Make Deals, Claude Science’s Debut, Vaccines for Neglected Diseases
Historic Biotech IPO, Merck, Protillion’s AI Deal, Testing a Lassa–Rabies Vaccine
A Billion-Dollar Deal, Trial Trouble, Biohub Updates, and Vaccine Research News
AI Scientists, Stock Tumble, Patent Lawsuit, and New Partnerships
Remembering J. Craig Venter, PhD
AI in Oncology Takes Off, Tackling HIV and Liver Disease, Pharma’s Recent Gains
Drugs from a Text Prompt, Wegovy Pill Competition Dampens Lilly’s Surge
Agentic AI, Virtual Cell, LNP Vaccine Boosters, Engineered Organs, and Mergers
Bacteria 4D Simulation, Safer Large Gene Insertion, uniQure Roller Coaster
AI for Scientists, FDA Reverses Course, and Advances in Cancer Therapeutics
Women in Science, Robotics, Automation, SLAS, and Lilly Updates
Ex-CEO Behind Bars, 10x’s Clinical Ambitions, and Pharma’s AI Gambit
Editors’ Choice: Top Stories of 2025
Lung Organoids, Autism and Sarcopenia Insights in Mice, and a Bidding War Ends
New Nasal Vaccines, Korro Stock Dips, J&J and Merck Acquisitions, and Dyno GATC
uniQure Staggers at FDA, Recursion's Microglia Map, and Leadership Transitions
Artificial Intelligence in the Emerald City and Targeting Colon Cancer Stem Cells
Nobel Prizes Announced and Breakthroughs for Huntington’s and Rare Diseases
BPI 2025 Debrief and Takeaways
Developing New Therapies Through Partnership, Electricity, and Immunotherapy
Stem Cells in Space and AI for Nanoparticles and Peptide Design
Reversing Parkinson’s in Mice, Protecting Primates from HIV, Top 10 Biotech Clusters, and Sarepta
Sarepta Under Scrutiny, AstraZeneca’s Big Bet, and AI vs. IDRs
Merck Acquires Verona, Virtual Cell Challenge, Gene Therapy Restores Hearing
BIO 2025, Huge Virtual Cell Dataset, AI-Designed De Novo Proteins
Rocket’s Gene Therapy Trial Paused, Boltz-2 Open Source, Plasma Swap Rewinds Aging
Customized CRISPR for KJ, 10x and Illumina Lawsuits, Regeneron Bags 23andMe
Insights into COVID-19’s Origins, Recursion Reverses Course, and AACR Stands Up for Cancer Research
Navigating Biotech’s New Normal, Applying AI to Cas9 Enzymes, and Sequencing Generations
Discussing De-Extinction, Trump’s Tariffs Touch Biopharma, and Reports from Recent Travels
Dravet Gene Therapy Tested in Mice, Sarepta’s Setback, and AstraZeneca Updates
Genetic Engineering at Asilomar, Stand Up for Science, and Francis Collins
AI Models Writing DNA and Designing Enzymes, Some Pre-AGBT News
Recursion Clinical Trial, CRISPR Delivery methods, preclinical Cas12 use, Gene Editing in AgBio, Top 10 Takeover Targets
DNA Day: Deep Dive
How Biotechs Are Plugging AI into Drug Discovery Problems
Launch of Nvelop Therapeutics for Delivery of Genetic Cargo, AACR Recap
Dried Blood COVID Dx, Cryo-Shocked Tumor Cell Delivery Vehicles, Verve Halts Trial, Iambic Starts Trial, and Diagonal Therapeutics Launches
AI in Drug Discovery and Precision Medicine: Nvidia GTC and Precision Med TRI-CON
Optimizing Nanoparticles and Messenger RNAs with Multiple “Tails”
NanoString Finds a Buyer, Slide Tags Enter in Early Access as Curio Trekker, Cellares Unveils Cell Therapy Manufacturing Platform
International Women’s Day, Nanoparticles and Delivery, Novo Nordisk’s Expansion, and Organoids for Congenital Conditions
Moderna Gets Back to Its Roots, Form Bio and Ginkgo Bioworks Team Up, and Under-the-Radar Rare Autoimmune Diseases
Prime Editing for Isogenic iPSCs, PRINT, Universal In Vivo CAR T Editing, Biogen Q4 Results Disappoint; Andrea Choe
CRISPRed Pigs, Exscientia Fires CEO, & AGBT Roundup; Christian Henry
Intellia and Ultragenyx’s Clinical Updates, Novo Holdings’ Catalent Acquisition, and NanoString Bankruptcy; Simon Barnett
Genome Interpretation, Nanoparticles, Gene Therapy, 2024 IPOs; Nautilus Biotechnology
Restoring Hearing Loss, CAR T Manufacturing, DNA-Based Medicines, Nvidia and Recursion; Eric Topol
Alzheimer’s Disease, Monkey Cloning, Cytokinetics Stock; Jen Nwankwo
J.P. Morgan 2024: Illumina, 10x, Danaher, AI; Liberate Bio
Novartis and Voyager, JPM Ahead, Epigenetic Engineering; Alex Aravanis
Launch of Tome Biosciences, AI scientist, mRNA vaccines
Autism, AI and Epigenetics; Nevan Krogan